Private Equity
Andrea Alms Video: Money In Motion 86 - Stem Cell Market - Part 1
December 2023 - Private Equity
TRANSCRIPT: Hello. My name is Andre and I am technology investor and financial manager and this is your money emotion. I was asked about mesenchymal stem cell market. What is it? STEM cells are specialized cells capable of renewing themselves through cell division and differentiate into multiple cell lines. The first clinical trial of MSC was completed by Auris Therapeutics in 1995.
The first regulatory approval of MSC was granted conditional approval in 2012, in Canada and New Zealand for treating graft versus host disease. According to Professor Leffler adds, As of September 1st, 2022, there are 32 approved stem cell therapies and drugs at Transparency markets. The global MSC market is 3.2 billion in 2022, an estimated compound average growth rate of 12.7%.
At Acumen, the market size is 1.7 billion in 2021. An estimated grow to 3.4 billion by 2030 at 8.1% growth rate. At Grandview, the market was 2.7 billion in 2022 and growing at 12.8%. Averaging the average is best guess $2.5 billion market size at 11.2% growth rate. Thank you. This is your money, your money, in motion.